Safety Guide · Updated July 2026

How to Verify a Legitimate Compounded GLP-1 Pharmacy in 2026

The FDA has flagged counterfeit compounded semaglutide products with fake pharmacy labels. With nearly 1,000 adverse events reported, knowing how to verify your source isn't optional — it's essential.

Why Verification Matters More Than Ever

The regulatory tightening around compounded GLP-1 medications in 2025 and 2026 has had an unintended side effect: as legitimate large-scale compounders have been forced to shut down or scale back, demand for affordable semaglutide hasn't decreased. That gap has attracted bad actors.

The FDA has specifically warned about fraudulent compounded semaglutide and tirzepatide products marketed in the US that contain false information on the label. In some cases, the pharmacies listed on the product labels don't exist. In others, real pharmacy names are being used without their knowledge or involvement. The FDA also flagged products sold as "for research purposes" or "not for human consumption" that are clearly being marketed for weight loss use with dosing instructions included.

This isn't theoretical risk. The FDA has documented adverse events requiring hospitalization that may be linked to unverified compounded products.

Step 1: Get the Pharmacy Name and Type

Before paying for anything, ask your telehealth provider or platform a direct question: which pharmacy compounds my medication, and is it a 503A or 503B facility?

A legitimate provider will answer this without hesitation. The pharmacy name, location, and type (503A or 503B) should be readily available. If the provider can't or won't tell you where your medication is compounded, that's your first and biggest red flag.

Step 2: Check State Licensing

Every state maintains a searchable database of licensed pharmacies through its board of pharmacy. For a 503A compounding pharmacy, this is the primary regulatory body. Search for the pharmacy by name and confirm that it holds a current, active license, it's authorized for sterile compounding (required for injectable medications like semaglutide), and there are no current disciplinary actions or sanctions on the license.

Most state board of pharmacy websites are freely accessible online. If you're not sure which state board to check, the pharmacy should be licensed in the state where it's physically located.

Step 3: Check FDA Registration (for 503B Facilities)

If the pharmacy claims to be a 503B outsourcing facility, it should be registered with the FDA. The FDA maintains a publicly available list of registered 503B outsourcing facilities on FDA.gov. Search for the facility by name. If it claims to be FDA-registered but doesn't appear on the list, that's a serious concern.

Keep in mind that being FDA-registered doesn't guarantee compliance — the FDA has issued warning letters to registered facilities for various violations. But registration is the baseline requirement. If a 503B facility isn't even registered, nothing else about it can be trusted.

Red Flags to Watch For

After reviewing FDA warnings, enforcement actions, and adverse event data, clear patterns emerge. The following are reliable warning signs that a GLP-1 source is not operating within the legal and safety framework.

No prescription required. Any source offering semaglutide without requiring a valid prescription from a licensed healthcare provider is operating illegally. Period. GLP-1 medications are prescription drugs — there is no legitimate pathway to purchase them over the counter.

"Research use" or "not for human consumption" labeling. The FDA has specifically called out this tactic. Products labeled this way that include dosing instructions and are marketed for weight loss are being sold illegally. The labeling is an attempt to circumvent pharmaceutical regulations.

No identifiable pharmacy. If the product packaging doesn't clearly identify the compounding pharmacy, or if the provider won't disclose which pharmacy fills the prescription, there's no way to verify the product's origin or quality.

Prices that seem too low. Compounded semaglutide has real costs — the active pharmaceutical ingredient, sterile compounding facilities, pharmacist time, and shipping. If a provider is offering prices dramatically below the $99-$300/month range that compliant providers typically charge, question how they're cutting costs.

No medical evaluation. A legitimate telehealth provider will screen for contraindications (thyroid cancer history, pancreatitis, etc.), review your medical history, and provide ongoing monitoring. If the "consultation" is just a form you fill out with no meaningful medical review, the provider isn't prioritizing patient safety.

What to Check When Your Medication Arrives

Once you receive your compounded semaglutide, inspect the product before use. The vial or syringe should clearly display the compounding pharmacy's name and contact information, your name (for 503A patient-specific prescriptions), the medication name and concentration, a beyond-use date, and storage instructions.

If any of this information is missing, or if the pharmacy name on the product doesn't match what your provider told you, contact your provider immediately before using the product. The FDA has documented cases of products with completely fabricated pharmacy labels.

When In Doubt, Verify

Verifying a compounding pharmacy takes 10 to 15 minutes. A state board of pharmacy database search, a check on the FDA's 503B registry if applicable, and a direct question to your provider about their pharmacy partner. That investment of time protects you from the real risks that exist in this market.

The providers who are operating legitimately want you to verify them. Their licensing and compliance is a competitive advantage — proof that they're operating within the legal framework while other operators cut corners. If a provider gets defensive or evasive when you ask about pharmacy credentials, you have your answer.

This article is for informational purposes only and does not constitute medical advice. Information about FDA enforcement actions and adverse event reports sourced from FDA.gov. Consult a licensed healthcare provider before starting any medication. Information current as of July 2026.